In order to identify somatic differences and potential susceptibility loci for CRC, we have compared high resolution (385 000 oligo probe array) DNA copy number profile and TP53 mutation status in carcinomas from late onset and early onset patients without known hereditary CRC syndromes. The gene discussed is TP53; the disease is carcinoma.